Literature DB >> 8259773

Bone mineral status of women with Marfan syndrome.

L Kohlmeier1, C Gasner, R Marcus.   

Abstract

PURPOSE: With effective surgical correction of vascular abnormalities, skeletal health is an important issue for patients with Marfan syndrome. Osteopenia has been radiographically described, yet no systematic evaluation of bone status has been published. The purpose of this study was to determine the bone mineral density (BMD, g/cm2) in women with Marfan syndrome. PATIENTS AND METHODS: Seventeen women, 37.2 +/- 7.3 years old, with Marfan syndrome were studied. Dual energy x-ray absorptiometry (DXA) was used to measure BMD at the lumbar spine (L2-L4), proximal femur, and total body in all subjects. Scoliosis scores were assigned from 0 (no curvature) to 3 (severe curvature).
RESULTS: Highly significant deficits in BMD were observed at the proximal femur (p = 0.0001) as well as of the whole body (p < 0.05). Femoral neck BMD Z-score (mean +/- SD) = -1.36 +/- 0.94, trochanter Z = -1.07 +/- 0.80, and intertrochanter Z = -1.44 +/- 0.71; whole-body BMD Z-score = -0.30 +/- 0.16. BMD at L2-L4, however, did not differ from age-predicted values, Z = -0.48 +/- 1.16. There was no significant association between BMD and scoliosis, nor between BMD and fracture history. To correct for bone size, the bone mineral apparent density (BMAD, g/cm3) was calculated. The femoral neck BMAD values (mean +/- SD) were significantly lower than predicted (0.125 +/- 0.02 versus 0.147 +/- 0.001 g/cm3, p < 0.001). All subjects had normal menarche, and 15 reported regular menses. There was no history of nontraumatic fracture.
CONCLUSIONS: Women with Marfan syndrome have bone deficits at the proximal femur as well as of the whole body. This deficit is not related to scoliosis and persists when corrected for bone size. Women with Marfan syndrome may be at increased risk for proximal femoral fracture.

Entities:  

Mesh:

Year:  1993        PMID: 8259773     DOI: 10.1016/0002-9343(93)90351-o

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  10 in total

1.  Differential effects of alendronate and losartan therapy on osteopenia and aortic aneurysm in mice with severe Marfan syndrome.

Authors:  Harikiran Nistala; Sui Lee-Arteaga; Luca Carta; Jason R Cook; Silvia Smaldone; Gabriella Siciliano; Aaron N Rifkin; Harry C Dietz; Daniel B Rifkin; Francesco Ramirez
Journal:  Hum Mol Genet       Date:  2010-09-24       Impact factor: 6.150

2.  Increased incident hip fractures in postmenopausal women with moderate to severe pelvic organ prolapse.

Authors:  Lubna Pal; Susan M Hailpern; Nanette F Santoro; Ruth Freeman; David Barad; Simon Kipersztok; Vanessa M Barnabei; Sylvia Wassertheil-Smoller
Journal:  Menopause       Date:  2011-09       Impact factor: 2.953

3.  Skeletogenic phenotype of human Marfan embryonic stem cells faithfully phenocopied by patient-specific induced-pluripotent stem cells.

Authors:  Natalina Quarto; Brian Leonard; Shuli Li; Melanie Marchand; Erica Anderson; Barry Behr; Uta Francke; Renee Reijo-Pera; Eric Chiao; Michael T Longaker
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-16       Impact factor: 11.205

4.  Assessment of bone mineral density in adults and children with Marfan syndrome.

Authors:  Philip F Giampietro; Margaret Peterson; Robert Schneider; Jessica G Davis; Cathleen Raggio; Elizabeth Myers; Stephen W Burke; Oheneba Boachie-Adjei; Charles M Mueller
Journal:  Osteoporos Int       Date:  2003-07-03       Impact factor: 4.507

5.  Bone mineral density determinations by dual-energy x-ray absorptiometry in the management of patients with Marfan syndrome--some factors which affect the measurement.

Authors:  Philip F Giampietro; Margaret G E Peterson; Robert Schneider; Jessica G Davis; Stephen W Burke; Oheneba Boachie-Adjei; Charles M Mueller; Cathleen L Raggio
Journal:  HSS J       Date:  2007-02

Review 6.  The ever-expanding conundrum of primary osteoporosis: aetiopathogenesis, diagnosis, and treatment.

Authors:  Stefano Stagi; Loredana Cavalli; Salvatore Seminara; Maurizio de Martino; Maria Luisa Brandi
Journal:  Ital J Pediatr       Date:  2014-06-07       Impact factor: 2.638

7.  Recapitulating and Correcting Marfan Syndrome in a Cellular Model.

Authors:  Jung Woo Park; Li Yan; Chris Stoddard; Xiaofang Wang; Zhichao Yue; Leann Crandall; Tiwanna Robinson; Yuxiao Chang; Kyle Denton; Enqin Li; Bin Jiang; Zhenwu Zhang; Kristen Martins-Taylor; Siu-Pok Yee; Hong Nie; Feng Gu; Wei Si; Ting Xie; Lixia Yue; Ren-He Xu
Journal:  Int J Biol Sci       Date:  2017-04-10       Impact factor: 6.580

8.  Assessment of Bones Deficient in Fibrillin-1 Microfibrils Reveals Pronounced Sex Differences.

Authors:  Lukas Altinbas; Nicole Bormann; Daniel Lehmann; Sarah Jeuthe; Dag Wulsten; Uwe Kornak; Peter N Robinson; Britt Wildemann; Georgios Kararigas
Journal:  Int J Mol Sci       Date:  2019-12-01       Impact factor: 5.923

Review 9.  The Musculoskeletal Manifestations of Marfan Syndrome: Diagnosis, Impact, and Management.

Authors:  Lily Pollock; Ashley Ridout; James Teh; Colin Nnadi; Dionisios Stavroulias; Alex Pitcher; Edward Blair; Paul Wordsworth; Tonia L Vincent
Journal:  Curr Rheumatol Rep       Date:  2021-11-26       Impact factor: 4.592

10.  Assessment of bone mineral status in children with Marfan syndrome.

Authors:  Monica Grover; Nicola Brunetti-Pierri; John Belmont; Kelly Phan; Alyssa Tran; Roman J Shypailo; Kenneth J Ellis; Brendan H Lee
Journal:  Am J Med Genet A       Date:  2012-08-07       Impact factor: 2.802

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.